Skip to content
knowrare
HealthSignal
Your condition community

Living with Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria

An extremely rare genetic condition with cartilage growths in the bones and high levels of a chemical in the urine.

Understanding Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria

Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria is an extremely rare genetic disorder that combines cartilage growths in bones (enchondromatosis) with a high urine level of D-2-hydroxyglutaric acid.

Features include short stature, bone changes near the ends of long bones, mild spine involvement, and mild developmental delay. It can start from birth to childhood.

Signs & symptoms

Symptoms vary from person to person. GARD lists these among the most common:

  • Cartilage growths in bones (enchondromatosis)
  • Short stature and growth delay
  • Widened, irregular bone ends
  • Flattened spine bones
  • Poor weight gain
  • Slow growth before birth

Not everyone has every symptom. GARD's list comes from the Human Phenotype Ontology.

Diagnosis

  1. Talk with your doctor

    Share the symptoms you've noticed, when they started and your family health history. Notes and photos can help.

  2. See a specialist

    Specialists who may be involved include bone and joint specialists and genetic specialists.

  3. Consider genetic testing

    Changes in IDH1 are linked to this condition. Genetic testing and counseling can help confirm a diagnosis and explain what it means for your family.

Care & treatment

Care team
Bone and joint specialists (orthopedists or orthopedic surgeons); Genetic specialists (geneticists)
Expert care
Ask about multidisciplinary care centers for rare conditions
Treatment
GARD doesn't list specific treatments for this condition. Your care team will tailor care to your symptoms.
Research
Clinical trials and observational studies may be options. See the research section below.

General information, not medical advice. Your care team makes the decisions.

Everyday life

Living with a rare condition is easier with support.

  • Connect with Organic Acidemia Association
  • Keep notes on symptoms, changes and questions for appointments
  • Ask about patient registries that help research
  • Look into financial aid and travel resources for care visits
Bring these questions to your next doctor visit
Should we have IDH1 genetic testing?
How should bone growths be monitored over time?
Which specialists should follow bones and metabolism?

Quick facts

Symptoms usually startfrom Birth to Childhood
GenesIDH1

Changes in the IDH1 gene cause this condition.

Genetic

Also known as: mc-hga; metaphyseal enchondrodysplasia with 2-hydroxyglutaric aciduria; metaphyseal enchondromatosis with d-2-hydroxyglutaric aciduria; spondyloenchondromatosis with d-2-hydroxyglutaric aciduria

Patient organizations

Source: NIH GARD · Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduriaGARD ID 16902 · GARD page updated September 2026 · Plain-language summary by Know Rare; editorial review pending. General information, not medical advice.

You are more than your diagnosis

Perspectives from people navigating life with Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria.

Explore the Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria blog

Explore research for Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria

Explore actively recruiting Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria studies with HealthSpark.

HealthSpark

Find actively recruiting studies for Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria with HealthSpark. Share your city to explore research near you.

  • Recruiting studies from ClinicalTrials.gov
  • Share your city to look for research near you
  • Eligibility is confirmed by the study team

Powered by HealthSpark, our AI chat helper

I can help you find recruiting Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria studies. Enter a ZIP code, address or city below and I'll look within 50 miles.

Powered by HealthSpark, our AI chat helper · Study information from ClinicalTrials.gov · Eligibility is confirmed by the study team.

Get Signals for Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria

Stay in the loop with community stories and updates from medical researchers.

HealthStoryfor Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria

Create a living journal that talks back

HealthStory evolves private journaling with a living AI journal that talks back and asks thoughtful questions, helping you capture your Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria experiences more deeply and prepare for better conversations with your doctors and care team.

Start your journal

Your journal is private. Sharing your story publicly is a separate choice, made with Share your story above.